BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28528397)

  • 21. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS; Colak R; Keleştimur F; Selçuklu A; Unlühizarci K; Bayram F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.
    Kristof RA; Wichers M; Haun D; Redel L; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2008 Apr; 150(4):329-35; discussion 335. PubMed ID: 18309452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate.
    Xiao E; Xia-Zhang L; Vulliémoz NR; Ferin M; Wardlaw SL
    Endocrinology; 2003 May; 144(5):1736-41. PubMed ID: 12697678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system.
    Jiang S; Zhu J; Feng M; Yao Y; Deng K; Xing B; Lian W; Wang R; Bao X
    Pituitary; 2021 Aug; 24(4):564-573. PubMed ID: 33651318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
    Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
    Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
    Giordano R; Bo M; Pellegrino M; Vezzari M; Baldi M; Picu A; Balbo M; Bonelli L; Migliaretti G; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5656-62. PubMed ID: 16014406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors.
    Goyal-Honavar A; Sarkar S; Asha HS; Kapoor N; Balakrishnan R; Vanjare H; Chacko G; Chacko AG
    Acta Neurochir (Wien); 2021 Nov; 163(11):3143-3154. PubMed ID: 34181087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of clinically silent corticotroph macroadenomas.
    Guttenberg KB; Mayson SE; Sawan C; Kharlip J; Lee JY; Martinez-Lage M; Loevner LA; Ewanichak J; Grady MS; Snyder PJ
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):874-880. PubMed ID: 27346850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB; Landman RE; Wardlaw SL; Conwell IM; Freda PU
    Pituitary; 2005; 8(2):115-22. PubMed ID: 16379031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
    Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis.
    Teshima T; Matsumoto H; Okusa T; Nakamura Y; Koyama H
    PLoS One; 2015; 10(8):e0135516. PubMed ID: 26262685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas.
    Cazabat L; Dupuy M; Boulin A; Bernier M; Baussart B; Foubert L; Raffin-Sanson ML; Caron P; Bertherat J; Gaillard S
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):566-72. PubMed ID: 24601912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of standard deviation score of log-transformed serum dehydroepiandrosterone sulfate in patients with hypothalamic-pituitary-adrenal axis insufficiency.
    Edo N; Morita K; Ishiwata C; Nakajima R; Sayama Y; Suzuki T; Sakamoto M; Okamoto K; Uchino T; Ozawa Y; Uno K; Uno K; Tsukamoto K; Ishikawa T
    Endocr J; 2021 Nov; 68(11):1337-1345. PubMed ID: 34162776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of the Hypothalamic-Pituitary-Adrenal Axis in a Male Rat Chronic Stress Model.
    Franco AJ; Chen C; Scullen T; Zsombok A; Salahudeen AA; Di S; Herman JP; Tasker JG
    Endocrinology; 2016 Jun; 157(6):2346-55. PubMed ID: 27054552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.